{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:47:15Z","timestamp":1783432035717,"version":"3.54.6"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005972","name":"German Cancer Aid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001858","name":"Sweden's Innovation Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.semcancer.2021.05.026","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T04:29:12Z","timestamp":1621830552000},"page":"242-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Trailblazing precision medicine in Europe: A joint view by Genomic Medicine Sweden and the Centers for Personalized Medicine, ZPM, in Germany"],"prefix":"10.1016","volume":"84","author":[{"given":"Albrecht","family":"Stenzinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Edsj\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Ploeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikaela","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7907-4595","authenticated-orcid":false,"given":"Stefan","family":"Fr\u00f6hling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3811-5439","authenticated-orcid":false,"given":"Valtteri","family":"Wirta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Seufferlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Botling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justus","family":"Duyster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0494-1727","authenticated-orcid":false,"given":"Michael","family":"Akhras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Thimme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thoas","family":"Fioretos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4463-8263","authenticated-orcid":false,"given":"Michael","family":"Bitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Cavelier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schirmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisar","family":"Malek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0211-8788","authenticated-orcid":false,"given":"Richard","family":"Rosenquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lindstrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wedell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gisselsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Mel\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Helenius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Ehrencrona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Engstrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Palmqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars-\u00c5ke","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lovisa","family":"Lovmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00e9ne","family":"Landstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hallbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Wadelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Sikora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambros J.","family":"Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"Illert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Budczies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Nikolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Kohlbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Horak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Boerries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Lassmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena I.","family":"Gaidzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.semcancer.2021.05.026_bib0005","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrd.2016.110","article-title":"Reining in the supersized Phase I cancer trial","volume":"15","author":"Mullard","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"Suppl","key":"10.1016\/j.semcancer.2021.05.026_bib0010","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/j.semcancer.2015.03.004","article-title":"Immune evasion in cancer: mechanistic basis and therapeutic strategies","volume":"35","author":"Vinay","year":"2015","journal-title":"Semin. Cancer Biol."},{"issue":"3","key":"10.1016\/j.semcancer.2021.05.026_bib0015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10654-018-0385-9","article-title":"Epidemiology in wonderland: big data and precision medicine","volume":"33","author":"Saracci","year":"2018","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.semcancer.2021.05.026_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2020.07.014","article-title":"Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group","author":"Mosele","year":"2020","journal-title":"Ann. Oncol."},{"issue":"Suppl 5","key":"10.1016\/j.semcancer.2021.05.026_bib0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12918-017-0464-7","article-title":"A systematic analysis of FDA-approved anticancer drugs","volume":"11","author":"Sun","year":"2017","journal-title":"BMC Syst. Biol."},{"issue":"6","key":"10.1016\/j.semcancer.2021.05.026_bib0030","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat. Med."},{"issue":"24","key":"10.1016\/j.semcancer.2021.05.026_bib0035","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1182\/blood-2015-08-664649","article-title":"Integrated genomic DNA\/RNA profiling of hematologic malignancies in the clinical setting","volume":"127","author":"He","year":"2016","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.semcancer.2021.05.026_bib0040","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1526613","article-title":"Integrated analysis of the immunological and genetic status in and across cancer types: impact of mutational signatures beyond tumor mutational burden","volume":"7","author":"Budczies","year":"2018","journal-title":"Oncoimmunology"},{"issue":"7463","key":"10.1016\/j.semcancer.2021.05.026_bib0045","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.semcancer.2021.05.026_bib0050","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/mdy495","article-title":"Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic","volume":"30","author":"Chan","year":"2019","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.semcancer.2021.05.026_bib0055","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/d41573-019-00182-w","article-title":"Trends in clinical development for PD-1\/PD-L1 inhibitors","volume":"19","author":"Xin Yu","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.semcancer.2021.05.026_bib0060","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/d41573-019-00167-9","article-title":"Immuno-oncology drug development goes global","volume":"18","author":"Xin Yu","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"25","key":"10.1016\/j.semcancer.2021.05.026_bib0065","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1911361","article-title":"Olaparib plus bevacizumab as first-line maintenance in ovarian cancer","volume":"381","author":"Ray-Coquard","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.semcancer.2021.05.026_bib0070","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1911440","article-title":"Olaparib for metastatic castration-resistant prostate cancer","volume":"382","author":"de Bono","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.semcancer.2021.05.026_bib0075","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S1470-2045(20)30445-9","article-title":"Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study","volume":"21","author":"Marabelle","year":"2020","journal-title":"Lancet Oncol."},{"issue":"26","key":"10.1016\/j.semcancer.2021.05.026_bib0080","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.semcancer.2021.05.026_bib0085","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(19)30691-6","article-title":"Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1\u20132 trials","volume":"21","author":"Doebele","year":"2020","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.semcancer.2021.05.026_bib0090","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1470-2045(19)30856-3","article-title":"Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1\/2 clinical trials","volume":"21","author":"Hong","year":"2020","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.semcancer.2021.05.026_bib0095","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nm.2323","article-title":"Cancer genomics: from discovery science to personalized medicine","volume":"17","author":"Chin","year":"2011","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.semcancer.2021.05.026_bib0100","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1377\/hlthaff.2017.1624","article-title":"Precision medicine: from science to value","volume":"37","author":"Ginsburg","year":"2018","journal-title":"Health Aff. (Millwood)"},{"issue":"3","key":"10.1016\/j.semcancer.2021.05.026_bib0105","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1172\/JCI126119","article-title":"Promises, promises, and precision medicine","volume":"129","author":"Joyner","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.semcancer.2021.05.026_bib0110","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13073-016-0362-4","article-title":"Integrating precision cancer medicine into healthcare-policy, practice, and research challenges","volume":"8","author":"Bertier","year":"2016","journal-title":"Genome Med."},{"issue":"5","key":"10.1016\/j.semcancer.2021.05.026_bib0115","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/s41436-018-0315-y","article-title":"A logic model for precision medicine implementation informed by stakeholder views and implementation science","volume":"21","author":"Chanfreau-Coffinier","year":"2019","journal-title":"Genet. Med."},{"issue":"2","key":"10.1016\/j.semcancer.2021.05.026_bib0120","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/jlb\/lsw018","article-title":"Precision medicine: drowning in a regulatory soup?","volume":"3","author":"Nicol","year":"2016","journal-title":"J. Law Biosci."},{"issue":"12","key":"10.1016\/j.semcancer.2021.05.026_bib0125","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nrd.2016.206","article-title":"Precision medicine and the changing role of regulatory agencies","volume":"15","author":"Breckenridge","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.semcancer.2021.05.026_bib0130","first-page":"153","article-title":"The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment","volume":"68","author":"Carrera","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.semcancer.2021.05.026_bib0135","unstructured":"Genomic Medicine Sweden. https:\/\/genomicmedicine.se\/. (Accessed 22.10. 2020)."},{"key":"10.1016\/j.semcancer.2021.05.026_bib0140","unstructured":"SciLifeLab. https:\/\/www.scilifelab.se\/. (Accessed 28.10. 2020)."},{"key":"10.1016\/j.semcancer.2021.05.026_bib0145","article-title":"Life science-strategin \u2013 f\u00f6r b\u00e4ttre h\u00e4lsa och st\u00e4rkt konkurrenskraft","author":"Nordborg","year":"2019","journal-title":"regeringen.se"},{"key":"10.1016\/j.semcancer.2021.05.026_bib0150","unstructured":"Vinnova. https:\/\/www.vinnova.se\/en\/. (Accessed 28.10. 2020)."},{"key":"10.1016\/j.semcancer.2021.05.026_bib0155","unstructured":"Swelife. https:\/\/swelife.se\/en. (Accessed 28.10. 2020)."},{"key":"10.1016\/j.semcancer.2021.05.026_bib0160","series-title":"Joint Effort to Develop Whole-genome Sequencing for Patients With Acute Leukemia","year":"2020"},{"issue":"1","key":"10.1016\/j.semcancer.2021.05.026_bib0165","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13073-019-0675-1","article-title":"From cytogenetics to cytogenomics: whole-genome sequencing as a first-line test comprehensively captures the diverse spectrum of disease-causing genetic variation underlying intellectual disability","volume":"11","author":"Lindstrand","year":"2019","journal-title":"Genome Med."},{"issue":"7814","key":"10.1016\/j.semcancer.2021.05.026_bib0170","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41586-020-2434-2","article-title":"Whole-genome sequencing of patients with rare diseases in a national health system","volume":"583","author":"Turro","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2021.05.026_bib0175","series-title":"The Ministry of Social Affairs and Health (Finland), Secondary Use of Health and Social Data","year":"2021"},{"key":"10.1016\/j.semcancer.2021.05.026_bib0180","unstructured":"Zentren f\u00fcr Personalisierte Medizin. https:\/\/zpm-verbund.de\/. (Accessed 21.10. 2020)."},{"key":"10.1016\/j.semcancer.2021.05.026_bib0185","series-title":"McKinsey Personalized Medicine Compendium \u201cThe Path Forward\u201d","author":"Kulkani","year":"2013"},{"key":"10.1016\/j.semcancer.2021.05.026_bib0190","doi-asserted-by":"crossref","first-page":"f6690","DOI":"10.1136\/bmj.f6690","article-title":"Genomes of 100,000 people will be sequenced to create an open access research resource","volume":"347","author":"Torjesen","year":"2013","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.semcancer.2021.05.026_bib0195","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41576-019-0156-9","article-title":"Leveraging European infrastructures to access 1 million human genomes by 2022","volume":"20","author":"Saunders","year":"2019","journal-title":"Nat. Rev. Genet."},{"issue":"4","key":"10.1016\/j.semcancer.2021.05.026_bib0200","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/annonc\/mdy054","article-title":"Introducing whole-genome sequencing into routine cancer care: the Genomics England 100 000 Genomes Project","volume":"29","author":"Turnbull","year":"2018","journal-title":"Ann. Oncol."},{"issue":"10","key":"10.1016\/j.semcancer.2021.05.026_bib0205","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/gim.2017.241","article-title":"Clinical whole-genome sequencing from routine formalin-fixed, paraffin-embedded specimens: pilot study for the 100,000 genomes project","volume":"20","author":"Robbe","year":"2018","journal-title":"Genet. Med."},{"issue":"4","key":"10.1016\/j.semcancer.2021.05.026_bib0210","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41588-020-0603-8","article-title":"A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer","volume":"52","author":"Wagner","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcancer.2021.05.026_bib0215","series-title":"Personalised Medicine for the Benefit of Patients","year":"2016"},{"key":"10.1016\/j.semcancer.2021.05.026_bib0220","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/978-3-319-67144-4_22","article-title":"Personalized medicine: what\u2019s in it for rare diseases?","volume":"1031","author":"Schee Genannt Halfmann","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"6","key":"10.1016\/j.semcancer.2021.05.026_bib0225","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.trsl.2009.03.008","article-title":"Drug development for orphan diseases in the context of personalized medicine","volume":"154","author":"Brewer","year":"2009","journal-title":"Transl. Res."},{"key":"10.1016\/j.semcancer.2021.05.026_bib0230","doi-asserted-by":"crossref","first-page":"118","DOI":"10.14694\/EdBook_AM.2013.33.118","article-title":"Strategies to overcome clinical, regulatory, and financial challenges in the implementation of personalized medicine","author":"Tsimberidou","year":"2013","journal-title":"American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting"},{"key":"10.1016\/j.semcancer.2021.05.026_bib0235","series-title":"The Value of Public-Private Partnerships in the Netherlands","author":"Groen","year":"2019"},{"key":"10.1016\/j.semcancer.2021.05.026_bib0240","unstructured":"France Genomique. https:\/\/www.france-genomique.org\/?lang=en. (Accessed 28.10. 2020)."},{"issue":"9","key":"10.1016\/j.semcancer.2021.05.026_bib0245","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00038-019-01298-x","article-title":"Cost-effectiveness of precision medicine: a scoping review","volume":"64","author":"Kasztura","year":"2019","journal-title":"Int. J. Public Health"},{"key":"10.1016\/j.semcancer.2021.05.026_bib0250","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.lungcan.2016.05.024","article-title":"Cost-effectiveness of precision medicine in the fourth-line treatment of metastatic lung adenocarcinoma: an early decision analytic model of multiplex targeted sequencing","volume":"107","author":"Doble","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.semcancer.2021.05.026_bib0255","article-title":"Integrating proteomics into precision oncology","author":"Wahjudi","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"7605","key":"10.1016\/j.semcancer.2021.05.026_bib0260","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature18003","article-title":"Proteogenomics connects somatic mutations to signalling in breast cancer","volume":"534","author":"Mertins","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.semcancer.2021.05.026_bib0265","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.cell.2019.03.030","article-title":"Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities","volume":"177","author":"Vasaikar","year":"2019","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.semcancer.2021.05.026_bib0270","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s12276-018-0071-8","article-title":"Single-cell RNA sequencing technologies and bioinformatics pipelines","volume":"50","author":"Hwang","year":"2018","journal-title":"Exp. Mol. Med."},{"issue":"6","key":"10.1016\/j.semcancer.2021.05.026_bib0275","doi-asserted-by":"crossref","first-page":"e8746","DOI":"10.15252\/msb.20188746","article-title":"Current best practices in single-cell RNA-seq analysis: a tutorial","volume":"15","author":"Luecken","year":"2019","journal-title":"Mol. Syst. Biol."},{"issue":"408","key":"10.1016\/j.semcancer.2021.05.026_bib0280","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan4730","article-title":"Single-cell analyses to tailor treatments","volume":"9","author":"Shalek","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.semcancer.2021.05.026_bib0285","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.cell.2020.06.038","article-title":"Spatial transcriptomics and in situ sequencing to study Alzheimer\u2019s disease","volume":"182","author":"Chen","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.semcancer.2021.05.026_bib0290","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/s41467-019-09018-y","article-title":"Breast cancer quantitative proteome and proteogenomic landscape","volume":"10","author":"Johansson","year":"2019","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.semcancer.2021.05.026_bib0295","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/s41592-018-0175-z","article-title":"Spatial organization of the somatosensory cortex revealed by osmFISH","volume":"15","author":"Codeluppi","year":"2018","journal-title":"Nat. Methods"},{"issue":"5","key":"10.1016\/j.semcancer.2021.05.026_bib0300","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1172\/JCI130787","article-title":"Targetable ERBB2 mutations identified in neurofibroma\/schwannoma hybrid nerve sheath tumors","volume":"130","author":"Ronellenfitsch","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.semcancer.2021.05.026_bib0305","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1158\/1535-7163.MCT-17-1107","article-title":"Clinical next-generation sequencing for precision oncology in rare cancers","volume":"17","author":"Groisberg","year":"2018","journal-title":"Mol. Cancer Ther."},{"issue":"9","key":"10.1016\/j.semcancer.2021.05.026_bib0310","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1158\/2159-8290.CD-18-0036","article-title":"NRG1 fusions in KRAS wild-type pancreatic cancer","volume":"8","author":"Heining","year":"2018","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.semcancer.2021.05.026_bib0315","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/jnci\/djy196","article-title":"Seamless designs: current practice and considerations for early-phase drug development in oncology","volume":"111","author":"Hobbs","year":"2019","journal-title":"J. Natl. Cancer Inst."},{"issue":"12","key":"10.1016\/j.semcancer.2021.05.026_bib0320","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","article-title":"NTRK fusion-positive cancers and TRK inhibitor therapy","volume":"15","author":"Cocco","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7776","key":"10.1016\/j.semcancer.2021.05.026_bib0325","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-019-1600-x","article-title":"The drug rediscovery protocol facilitates the expanded use of existing anticancer drugs","volume":"574","author":"van der Velden","year":"2019","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.semcancer.2021.05.026_bib0330","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMp1606181","article-title":"Predicting the future - big data, machine learning, and clinical medicine","volume":"375","author":"Obermeyer","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2021.05.026_bib0335","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12920-015-0108-y","article-title":"From big data analysis to personalized medicine for all: challenges and opportunities","volume":"8","author":"Alyass","year":"2015","journal-title":"BMC Med. Genomics"},{"key":"10.1016\/j.semcancer.2021.05.026_bib0340","first-page":"1","article-title":"A review of a distributed high performance computing implementation","author":"Flanagan","year":"2020","journal-title":"J. Inf. Technol. Case Appl. Res."},{"key":"10.1016\/j.semcancer.2021.05.026_bib0345","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.is.2014.07.006","article-title":"The rise of \u201cbig data\u201d on cloud computing: review and open research issues","volume":"47","author":"Hashem","year":"2015","journal-title":"Inf. Syst."},{"issue":"3","key":"10.1016\/j.semcancer.2021.05.026_bib0350","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1057\/jit.2012.17","article-title":"A critical review of cloud computing: researching desires and realities","volume":"27","author":"Venters","year":"2012","journal-title":"J. Inf. Technol."},{"key":"10.1016\/j.semcancer.2021.05.026_bib0355","series-title":"Global Alliance for Genomics & Health","year":"2021"},{"issue":"3","key":"10.1016\/j.semcancer.2021.05.026_bib0360","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/23808993.2016.1176526","article-title":"Regulatory barriers to the advancement of precision medicine","volume":"1","author":"Pettitt","year":"2016","journal-title":"Expert Rev. Precis. Med. Drug Dev."},{"key":"10.1016\/j.semcancer.2021.05.026_bib0365","unstructured":"Danish National Genome Center. https:\/\/eng.ngc.dk\/. (Accessed 28.10. 2020)."},{"key":"10.1016\/j.semcancer.2021.05.026_bib0370","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fmed.2019.00034","article-title":"From big data to precision medicine","volume":"6","author":"Hulsen","year":"2019","journal-title":"Front. Med. (Lausanne)"},{"issue":"1","key":"10.1016\/j.semcancer.2021.05.026_bib0375","article-title":"Big hopes for big data","volume":"26","year":"2020","journal-title":"Nat. Med."},{"issue":"38","key":"10.1016\/j.semcancer.2021.05.026_bib0380","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1200\/EDBK_200759","article-title":"Art and challenges of precision medicine: interpreting and integrating genomic data into clinical practice","author":"Madhavan","year":"2018","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"issue":"7","key":"10.1016\/j.semcancer.2021.05.026_bib0385","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/s41591-020-0969-2","article-title":"Support systems to guide clinical decision-making in precision oncology: the cancer core Europe molecular tumor board portal","volume":"26","author":"Tamborero","year":"2020","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2021.05.026_bib0390","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2217\/pme.14.65","article-title":"Ethical, legal and social implications of incorporating personalized medicine into healthcare","volume":"12","author":"Brothers","year":"2015","journal-title":"Per. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2021.05.026_bib0395","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tips.2016.11.007","article-title":"Implementing precision medicine: the ethical challenges","volume":"38","author":"Korngiebel","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.semcancer.2021.05.026_bib0400","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/MLR.0000000000000467","article-title":"Racial and ethnic disparities in health care access and utilization under the affordable care act","volume":"54","author":"Chen","year":"2016","journal-title":"Med. Care"},{"issue":"1 Pt 2","key":"10.1016\/j.semcancer.2021.05.026_bib0405","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1475-6773.2011.01308.x","article-title":"Nonfinancial barriers and access to care for U.S. adults","volume":"47","author":"Kullgren","year":"2012","journal-title":"Health Serv. Res."},{"key":"10.1016\/j.semcancer.2021.05.026_bib0410","series-title":"European\u2019 1+ Million Genomes\u2019 Initiative","year":"2021"},{"issue":"Suppl 7","key":"10.1016\/j.semcancer.2021.05.026_bib0415","doi-asserted-by":"crossref","first-page":"S295","DOI":"10.4103\/2152-7806.139612","article-title":"Multidisciplinary In-hospital Teams Improve Patient Outcomes: a Review","volume":"5","author":"Epstein","year":"2014","journal-title":"Surg. Neurol. Int."},{"issue":"39","key":"10.1016\/j.semcancer.2021.05.026_bib0420","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1200\/EDBK_236857","article-title":"The value and future developments of multidisciplinary team cancer care","author":"Selby","year":"2019","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"10.1016\/j.semcancer.2021.05.026_bib0425","first-page":"28","article-title":"Interdisciplinary training to build an informatics workforce for precision medicine","volume":"6","author":"Williams","year":"2015","journal-title":"Appl. Transl. Genom."},{"issue":"3","key":"10.1016\/j.semcancer.2021.05.026_bib0430","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/jlme.12078","article-title":"Patient advocacy organizations: institutional conflicts of interest, trust, and trustworthiness","volume":"41","author":"Rose","year":"2013","journal-title":"J. Law Med. Ethics"},{"key":"10.1016\/j.semcancer.2021.05.026_bib0435","unstructured":"Australian genomics. https:\/\/www.australiangenomics.org.au\/. (Accessed 21.10. 2020)."},{"issue":"5","key":"10.1016\/j.semcancer.2021.05.026_bib0440","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/ijc.30828","article-title":"Precision oncology based on omics data: the NCT Heidelberg experience","volume":"141","author":"Horak","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2021.05.026_bib0445","unstructured":"Cancer Core Europe. https:\/\/www.cancercoreeurope.eu\/. (Accessed 21.10. 2020)."},{"issue":"3","key":"10.1016\/j.semcancer.2021.05.026_bib0455","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/1878-0261.12447","article-title":"Cancer core Europe: a translational research infrastructure for a European mission on cancer","volume":"13","author":"Eggermont","year":"2019","journal-title":"Mol. Oncol."},{"issue":"4","key":"10.1016\/j.semcancer.2021.05.026_bib0460","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/annonc\/mdy027","article-title":"Genomic medicine France 2025","volume":"29","author":"Lethimonnier","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.semcancer.2021.05.026_bib0465","series-title":"Nationales Netzwerk Genomische Medizin Lungenkrebs","year":"2021"},{"key":"10.1016\/j.semcancer.2021.05.026_bib0470","series-title":"International Consortium for Personalised Medicine (ICPerMed)","year":"2021"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X21001565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X21001565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T23:55:49Z","timestamp":1760918149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X21001565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":93,"alternative-id":["S1044579X21001565"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2021.05.026","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trailblazing precision medicine in Europe: A joint view by Genomic Medicine Sweden and the Centers for Personalized Medicine, ZPM, in Germany","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2021.05.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}